Efficacy of Topical Boric Acid in the Treatment of Experimental Pseudomonas Aeruginosa Keratitis in Rats
INTRODUCTION: It was aimed to investigate the effect of topical boric acid on healing in the treatment of keratitis. METHODS: Keratitis was created by randomly 32 of 56 healthy rats with inoculating pseudomonas aeruginosa (1x108 colony-forming units/ml 0.05 ml of solution containing pseudomonas eruginosa-PA-ATC27853) by creating epithelial defects in the corneas and randomly distributed to 4 groups. The remaining 24 healthy rats were randomly divided into 3 groups, so that; group 1 (control group), group 2 (with pseudomonas keratitis), group 3 (with pseudomonas keratitis and 4% boric acid treatment), group 4 (with pseudomonas keratitis and 8% boric acid treatment), group 5 (with pseudomonas keratitis and vancomycin+ ceftazidime given), group 6 (non-keratitis and only 4% boric acid applied), group 7 (non-keratitis and only 8% boric acid applied). At the end of the study, the ocular tissues of the rats were removed and examined histopathologically. RESULTS: A clinically significant reduction in inflammation was detected in the groups using topical boric acid (p˂0,05). Decreased TGF-β1 staining was detected in the groups in which keratitis + %4 and %8 boric acid was treated topically (p˂0,05). Compared to the infected group (group 2), 4% and 8% boric acid administered groups revealed mild/moderate corneal edema and thickening, degeneration of the corneal epithelium, and mild/moderate inflammation in the interstitial (p˂0,05). DISCUSSION AND CONCLUSION: Topical boric acid drops may be an important therapeutic factor in tissue healing and in the fight against inflammation in the treatment of keratitis..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
---|---|
Enthalten in: |
Van Tıp Dergisi - 30(2023), 1, Seite 60-65 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Osman Ondas [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
---|
doi: |
10.5505/vtd.2023.15425 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ080216714 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ080216714 | ||
003 | DE-627 | ||
005 | 20240414102750.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230310s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.5505/vtd.2023.15425 |2 doi | |
035 | |a (DE-627)DOAJ080216714 | ||
035 | |a (DE-599)DOAJ7aa57164a5284fdda1dd5983b12502e7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a Osman Ondas |e verfasserin |4 aut | |
245 | 1 | 0 | |a Efficacy of Topical Boric Acid in the Treatment of Experimental Pseudomonas Aeruginosa Keratitis in Rats |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a INTRODUCTION: It was aimed to investigate the effect of topical boric acid on healing in the treatment of keratitis. METHODS: Keratitis was created by randomly 32 of 56 healthy rats with inoculating pseudomonas aeruginosa (1x108 colony-forming units/ml 0.05 ml of solution containing pseudomonas eruginosa-PA-ATC27853) by creating epithelial defects in the corneas and randomly distributed to 4 groups. The remaining 24 healthy rats were randomly divided into 3 groups, so that; group 1 (control group), group 2 (with pseudomonas keratitis), group 3 (with pseudomonas keratitis and 4% boric acid treatment), group 4 (with pseudomonas keratitis and 8% boric acid treatment), group 5 (with pseudomonas keratitis and vancomycin+ ceftazidime given), group 6 (non-keratitis and only 4% boric acid applied), group 7 (non-keratitis and only 8% boric acid applied). At the end of the study, the ocular tissues of the rats were removed and examined histopathologically. RESULTS: A clinically significant reduction in inflammation was detected in the groups using topical boric acid (p˂0,05). Decreased TGF-β1 staining was detected in the groups in which keratitis + %4 and %8 boric acid was treated topically (p˂0,05). Compared to the infected group (group 2), 4% and 8% boric acid administered groups revealed mild/moderate corneal edema and thickening, degeneration of the corneal epithelium, and mild/moderate inflammation in the interstitial (p˂0,05). DISCUSSION AND CONCLUSION: Topical boric acid drops may be an important therapeutic factor in tissue healing and in the fight against inflammation in the treatment of keratitis. | ||
650 | 4 | |a boric acid | |
650 | 4 | |a pseudomonas aeruginosa | |
650 | 4 | |a keratitis. | |
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
700 | 0 | |a Bahadir Utlu |e verfasserin |4 aut | |
700 | 0 | |a Kemal Bayrakceken |e verfasserin |4 aut | |
700 | 0 | |a Serkan Yildirim |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Van Tıp Dergisi |d Van Yuzuncu Yil University, School of Medicine, 2022 |g 30(2023), 1, Seite 60-65 |w (DE-627)DOAJ000158844 |x 25870351 |7 nnns |
773 | 1 | 8 | |g volume:30 |g year:2023 |g number:1 |g pages:60-65 |
856 | 4 | 0 | |u https://doi.org/10.5505/vtd.2023.15425 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/7aa57164a5284fdda1dd5983b12502e7 |z kostenfrei |
856 | 4 | 0 | |u https://jag.journalagent.com/z4/download_fulltext.asp?pdir=vtd&un=VTD-15425 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2587-0351 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 30 |j 2023 |e 1 |h 60-65 |